Reproductive and metabolic effects of recombinant equine leptin on seasonally anovulatory mares by Mitcham, Pamela Boliew
Louisiana State University
LSU Digital Commons
LSU Master's Theses Graduate School
2007
Reproductive and metabolic effects of recombinant
equine leptin on seasonally anovulatory mares
Pamela Boliew Mitcham
Louisiana State University and Agricultural and Mechanical College, pboliew@lsu.edu
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_theses
Part of the Animal Sciences Commons
This Thesis is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU
Master's Theses by an authorized graduate school editor of LSU Digital Commons. For more information, please contact gradetd@lsu.edu.
Recommended Citation
Mitcham, Pamela Boliew, "Reproductive and metabolic effects of recombinant equine leptin on seasonally anovulatory mares" (2007).







REPRODUCTIVE AND METABOLIC EFFECTS OF RECOMBINANT  















Submitted to the Graduate Faculty of the 
Louisiana State University and 
Agricultural and Mechanical College 
in partial fulfillment of the 
requirements for the degree of 




The Interdepartmental Program in Animal,  











Pamela Boliew Mitcham 





 I would like to express my gratitude to my major professor, Dr. Donald L. Thompson, Jr., 
for all of his patient guidance, counsel, and support during my graduate career at LSU.  Also, my 
sincere appreciation goes to Dr. Cathleen C. Williams and Dr. Dennis D. French for their 
willingness to serve as members of my graduate committee and for their contributions to my 
success.  To Dr. Laura R. Gentry, thank you so much for all of your ideas regarding this project 
and for all your assistance in the lab.  I am also grateful to Mr. Franklin “Randy” Wright and his 
staff at the LSU Horse Unit for their assistance throughout my years spent there.  A huge thank 
you also goes to Dr. Robert A. Godke for the use of the horses and facilities at the Reproductive 
Biology Center in St. Gabriel, and to Dr. Ariel Gertler, Hebrew University of Jerusalem, 
Rehovot, Israel, for providing the recombinant equine leptin used in my research. 
 To my fellow graduate students:  your friendships are some of the most important gifts I 
take away from graduate school.  I am forever indebted to Dr. William A. Storer for his countless 
hours of instruction and assistance during my time in this program.  To Kristian K. Kelley, I 
appreciate so much all of your long hours and cold nights at the farm and for your listening ear.  
To Nan K. Huff and Maxon M. Graham, thank you so much for your help and your friendship. 
 To my parents, Mary and Garry Jefferson and Jackie and Joyce Boliew, thank you for 
teaching me to dream big and for all your prayers.  To Mark, Lori, and Stephanie Seagroves and 
Cullen, Pam, Stephanie, and Rivers Saucier:  thank you for believing in me.  Also, to my dear 
friends Laz and Dánys Castillo and Natasha Romero: thank you for all your support.  Finally, to 
my husband, David:  this would have never happened without you!  Thank you for being my 
rock and my inspiration.  And most of all, thank you to my Lord and Savior, Jesus Christ for 
blessing me with so many gifts and for helping me through this journey.  The glory is His alone. 
 iii
TABLE OF CONTENTS 
ACKNOWLEDGMENTS……………………………………………………………      ii 
LIST OF TABLES……………………………………………………………………     iv 
LIST OF FIGURES…………………………………………………………………..      v 
ABSTRACT………………………………………………………………………….     vi 
INTRODUCTION ……………………………………………………………………     1 
REVIEW OF LITERATURE……………………………………….......................…      3 
 Hypothalamic-pituitary axis…………………………………………………..      3 
 Estrous cycle of the mare……………………………………………………..      4 
 Seasonality……………………………………………………………………      5 
 Folliculogenesis and follicular waves………………………………………..       7 
 Ovulation and the luteal phase……………………………………………….     10 
 Leptin…………………………………………………………………………    10 
 Rationale for present research......……………………………………………     16 
 
MATERIALS AND METHODS……………………………………………...…….      17 
 
RESULTS……………………………………………………………………......…..      20 
 
DISCUSSION……………………………………………………………......………      32 
 
SUMMARY AND CONCLUSIONS………………………………………………..      37 
 
LITERATURE CITED………………………………………………………………      38 
 




LIST OF TABLES 
 
1 Mean hay consumption, in kg and as a percent of body weight, consumed  
by leptin-treated and control mares…….......……………………………............22 
 
2 Mean age, body condition score (BCS), and day of first ovulation  
relative to the start of treatment (January 7)….......…………………….....……  22 
 v
LIST OF FIGURES 
 
1 Mean body weights collected on d –2, 16, 30, 46, 107, and 121, expressed 
 as a percent of pretreatment weight  ………………………………………….......…21 
 
2 Mean size of largest follicle of leptin-treated versus control mares 
from day –2 relative to the start of scanning (January 5) through  
day 72 (March 19)……………………………………… …………………………..23 
 
3 Mean plasma concentrations of prolactin for leptin-treated mares  
versus control mares from day –2 relative to the start of project  
(January 7) through day 57……………………………………………………….....24 
 
4 Mean plasma concentrations of triiodothyronine (T3) in leptin-treated  
mares versus control mares from d –2 relative to the start of the project  
(January 7) through day 57……………………………………………………….....25 
 
5 Mean plasma concentrations of thyroxine for leptin-treated versus 
control mares from day –2 relative to the start of the project (January 7)  
through day 57……………………………………………………………………....26 
 
6 Mean plasma concentrations of growth hormone (GH) in leptin-treated  
mares versus control mares during a 24-h, frequent (every 30  
min) blood-sampling window………………………………………………….........27 
 
7 Mean plasma concentrations of prolactin in leptin-treated mares  
versus control mares during a 24-h, frequent (every 30 min)  
blood-sampling window…………………………………………………………......28 
 
8 Mean plasma concentrations of insulin in leptin-treated mares  
versus control mares during a 24-h, frequent (every 30 min)  
blood-sampling window…………………………………………………………......29 
 
9 Mean number of counts of radiolabeled human leptin immunoprecipitated  
from 4-µL samples of plasma from leptin-treated and control mares in the 




 Mares of poor body condition have low plasma leptin concentrations, while obese mares 
have the highest concentrations.  Leptin is a primary signal of body condition to the brain in 
other species; therefore, low leptin concentrations in thin mares could contribute to their 
extended anovulatory period in winter compared to obese mares.  The current experiment was 
designed to determine whether recombinant equine leptin, administered to seasonally 
anovulatory mares, would induce ovarian activity and ovulation in the winter.  Leptin effects on 
metabolism were also studied.  Beginning January 7, leptin-treated mares (n = 9) received daily 
i.m. injections of 10 mg recombinant equine leptin in saline and control mares (n = 10) received 
equivalent injections of gelatin.  Reproductive effects were assessed by daily blood samples and 
regular ultrasound examination of the ovaries.  Weights were also collected routinely.  In 
addition, mares were confined to individual pens and hay consumption was measured as a means 
of evaluating appetite.  A 24-h period of 30-min blood sampling was used to characterize 
hormone patterns.  Over the course of the experiment, there was no difference between groups in 
follicular activity, date of first ovulation, or prolactin in either daily or frequently collected blood 
samples.  Leptin-treated mares lost more (P < 0.0001) weight than control mares in the first 31 d; 
however, there was no difference in appetite as indicated by 24-h hay consumption.  Post-
experimental analysis revealed that leptin-treated mares developed antibodies (P < 0.001) against 
the injected leptin beginning around d 16.  Subsequent leptin treatment did not affect growth 
hormone secretion during the frequent blood sampling window.  Leptin treatment did not affect 
daily triiodothyronine concentrations; however, treated mares had lower (P < 0.016) daily 
thyroxine concentrations than control mares.  Treated mares also had a tendency (P = 0.11) to 
have lower insulin concentrations during the frequent sampling period.  In conclusion, daily 
treatment with recombinant equine leptin had an immediate effect on body weight without any 
 vii
effect on hay consumption.  Although leptin-treated mares had lower thyroxine concentrations 
and a tendency for lower insulin, no effect was observed on reproductive endpoints in the time 




 Leptin is a protein hormone that is secreted by adipocytes and serves several functions, 
including regulation of feed intake.  Another function of the hormone is as a signal to the brain 
regarding nutritional status of the individual (Houseknecht et al., 1998) and thereby to the 
reproductive system as well.   
Research has shown correlation of body condition, age, season, and gender with leptin 
concentrations in horses (Fitzgerald and McManus, 2000; Gentry et al., 2002a, b; Buff et al., 
2002; Cartmill et al., 2003a).  Leptin concentrations vary with season, with lower circulating 
concentrations occurring in winter regardless of age or nutritional status and body condition 
(Fitzgerald and McManus, 2000; Gentry et al., 2002a).  While aged mares have increased leptin 
concentrations compared to younger mares (Fitzgerald and McManus, 2000; Buff et al., 2002), 
leptin concentrations are higher in both groups in summer than winter (Fitzgerald and McManus, 
2000; Gentry et al., 2002a).  Additionally, mares and geldings have higher circulating leptin 
concentrations than stallions (Cartmill et al., 2003a).  Feed restriction, both long term (Gentry et 
al., 2002a) and short term (McManus and Fitzgerald, 2000), causes leptin concentrations to 
decline. 
 Multiple effects of leptin on reproduction have been observed.  It can restore reproductive 
function in sterile ob/ob mice (Barash et al., 1996; Chehab et al., 1997; Mounzih et al., 1997) and 
is required for the normal onset of puberty in humans, mice, and cattle (Ahima et al., 1996; 
Chehab et al., 1997; Garcia et al., 2002).  Research with horses has shown that a large number of 
mares of high body condition fail to enter an anovulatory state; some cycle normally for the 
duration of the traditional anovulatory season (Gentry et al., 2002a). 
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 Given that manipulation of the estrous cycle is a primary focus of the horse industry to 
meet the demand for foals born as near to January 1 as possible, researchers are continually 
looking for new and innovative ways to accomplish this goal.  The question arose whether or not 
treatment with exogenous leptin would induce early cyclicity in mares of normal body condition 
and leptin concentrations.  However, the lack of an economically viable source of leptin 
prevented the testing of this hypothesis in the past.  Recent production of recombinant equine 
leptin (A. Gertler, Hebrew University of Jerusalem, Rehovot, Israel) made it possible to pursue 
this line of research. 
 The experiment described herein was designed to determine if administration of 
recombinant equine leptin to seasonally anovulatory mares of normal body condition and leptin 
concentrations would, in fact, induce early onset of cyclicity and ovulation in winter.  At the 
same time, data were collected to determine, what, if any, metabolic effects might be observed.  
This would also provide additional methods for determining the efficacy of the recombinant 
equine leptin if no reproductive effects were observed. 
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REVIEW OF LITERATURE 
Hypothalamic-pituitary axis 
 Extensive research has led to a common understanding that the reproductive axis is 
managed by the production of gonadotropin releasing hormone (GnRH) by the hypothalamus.  In 
the horse, production of GnRH occurs throughout the hypothalamus (Irvine and Alexander, 
1993).  Once synthesized, GnRH is packaged and stored in secretory granules within the median 
eminence, which, when stimulated by neuronal activity, are released into capillaries of the 
primary plexus; GnRH travels to and acts upon receptors on the gonadotropes within the pars 
distalis of the adenohypophysis (Alexander and Irvine, 1993; Kainer, 1993). 
 Gonadotropin releasing hormone is responsible for stimulating the production of its own 
receptors on the gonadotropes (Clayton, 1989; Alexander and Irvine, 1993).  It is also 
responsible for the release of the gonadotropins, luteinizing hormone (LH) and follicle-
stimulating hormone (FSH) in the target cells of the adenohypophysis.  The release of GnRH is 
in a pulsatile fashion, the frequency of which may regulate the secretion of LH and FSH 
(Ginther, 1992; Alexander and Irvine, 1993).  More frequent pulses of GnRH (every 45 min) 
favor secretion of LH, while less frequent pulses (every 6 h) favor FSH (Alexander and Irvine, 
1993).  This is supported by the fact that during estrus, GnRH pulses occur at a rate of 2/h, 
resulting in high circulating concentrations of LH and low concentrations of FSH.  Conversely, 
during diestrus, GnRH pulses occur at a much less frequent rate (around 0.1/h), resulting in high 
FSH and low LH secretion (Alexander and Irvine, 1993). 
 Luteinizing hormone and FSH are glycoprotein hormones consisting of matching alpha 
chains and differing function-specific beta chains (Alexander and Irvine, 1993). Effects of the 
gonadotropins are exerted through binding with their specific ovarian receptors.  The receptors 
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for FSH are found mainly on the granulosa cells of the ovarian follicles, whereas LH receptors 
are located on the thecal cells of the pre-antral follicles (Alexander and Irvine, 1993).  Following 
antral development, LH receptors can also be found on the granulosa cells (Alexander and Irvine, 
1993).  The primary function of FSH is stimulation of follicular growth (Guyton and Hall, 2000); 
however, the final stages of follicular growth and ovulation are controlled by LH (Alexander and 
Irvine, 1993).  Accompanying follicular growth is the production of estradiol and inhibin as well 
as the release of progesterone by the corpus luteum (CL), which forms following ovulation.  
Each of these hormones provides a negative feedback mechanism on the hypothalamus and the 
adenohypophysis (Alexander and Irvine, 1993).  Therefore, a closely regulated feedback loop 
exists to assure balance of all hormones and their actions. 
Estrous cycle of the mare 
 The estrous cycle is defined as the period of time from the beginning of one estrus to the 
start of the next (Daels and Hughes, 1993).  According to Ginther (1992), the average estrous 
cycle is 21.7 d, with a range of 19.1 to 23.7 d.  The estrous cycle consists of 2 distinct phases:  
the follicular phase, commonly known as estrus, and the luteal phase, or diestrus (Daels and 
Hughes, 1993).  Circulating FSH causes the follicular growth that occurs during diestrus and 
early estrus.  Estrogen is then released by the follicles, resulting in the exhibition of sexual 
behavior and receptivity to the stallion (Daels and Hughes, 1993).  The average length of estrus 
is 6.5 d with a range of 4.5 to 8.9 d (Ginther, 1992).  The estrogen released by the growing 
follicles serves the dual purpose of stimulation of LH release through a positive feedback 
mechanism.  The follicles also release the hormone inhibin from the granulosa cells, which, 
along with estradiol, has a negative feedback effect on FSH release (Bergfelt and Ginther, 1985).  
The subsequent rise in LH leads to ovulation, or expulsion, of the oocyte from the dominant 
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follicle.  Ovulation typically occurs 24 to 48 h before the end of estrus (Daels and Hughes, 
1993), but can be quite variable among mares. 
 Following ovulation, the evacuated follicle develops into a CL, which secretes the 
progesterone that dominates the diestrus phase.  Ginther (1992) found that the duration of 
diestrus is 12.1 to 16.3 d following ovulation.  Under the influence of progesterone, a mare will 
not be sexually receptive to the stallion (Daels and Hughes, 1993).  The CL will persist for about 
14 d, and then begin to regress, allowing the mare to return to the estrus phase once more (Daels 
and Hughes, 1993). 
 There is a reciprocal pattern to the gonadotropins during the estrous cycle.  Generally 
speaking, when LH concentrations are high, FSH concentrations are low.  It is believed that LH 
is low during diestrus due to negative feedback from progesterone secreted by the CL, whereas 
the high concentrations of FSH are allowed because of a lack of negative feedback from the 
ovaries (Freedman et al., 1979).  Secretion of FSH occurs in surges at 10- to 11-d intervals 
(Evans and Irvine, 1975).  Initial development of multiple follicles (up to 20) is caused by the 
first FSH surge in early diestrus (Evans and Irvine, 1975).  The highest concentration of FSH 
occurs during mid-diestrus surge.  It is this surge that allows dominant follicles to develop 
further (Evans and Irvine, 1975).  Secretion of FSH begins to decrease as the follicular phase 
progresses, and LH secretion undergoes a sharp increase, peaking approximately 1 d after 
ovulation (Miller et al., 1980). 
Seasonality 
 Mares are considered to be seasonally polyestrous.  Most non-pregnant mares will exhibit 
repeated estrous cycles throughout the spring and summer months, commonly referred to as the 
breeding season, with many becoming reproductively quiescent during the winter months (Daels 
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and Hughes, 1993).  This phenomenon is modified by several factors, including nutrition and 
climate, but is controlled primarily by photoperiod (Daels and Hughes, 1993).  This period of 
decreased to absent reproductive activity in winter is best described as the anovulatory period. 
 Following the last ovulation of the breeding season, the mare will slowly enter an 
anovulatory state due to inadequate LH secretion and lack of final growth of an ovulatory follicle 
(Snyder et al., 1979).  The anovulatory period is divided into 3 phases by Ginther (1992).  The 
first is the receding phase, also called fall transition, which coincides with the autumnal equinox 
(September 21).  This phase is characterized by the failure to ovulate large follicles due to the 
absence of an LH surge (Ginther, 1992).  The pituitary reserves of LH decline steadily from mid-
breeding season to mid-anovulatory season (Silvia et al., 1986).  Following the receding phase is 
the inactive phase, during which few follicles develop beyond 10 to 20 mm (Ginther, 1992).  The 
last phase is known as the resurging phase, or vernal transition.  At this time the mare begins to 
recover from the anovulatory state (Ginther, 1992). 
 The anovulatory period is defined by Sharp and Davis (1993) as a time of sexual 
incompetence and indifference during the winter months.  The reason for this inactivity is 
believed to be the sharp decrease in GnRH secretion by the hypothalamus (Sylvia et al., 1986).  
Sharp and Grubaugh (1987) measured hypothalamic GnRH in pony mares using push-pull 
perfusion technique and found no detectable GnRH secretion in winter.  Additionally, Thompson 
et al. (1986, 1987) reported a distinct suppression of gonadotropins in the winter months.  It has 
been found, however, that some mares will display weak signs of estrus despite an absence of 
follicular activity (Ginther, 1992; Gentry et al., 2002a). 
 During the resurging phase, the span of time between the initial rise in FSH and first 
ovulation can be lengthy (Sharp and Davis, 1993).  Secretion of FSH will fluctuate, but increases 
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in LH remain absent until just before ovulation (Hines et al., 1991).  Also, as the first ovulation is 
approached, FSH secretion and pulse amplitude will actually decrease (Freedman et al., 1979; 
Silvia et al., 1986; Hines et al., 1991) due to the production of inhibitory factors (estradiol and 
inhibin) from large follicles (Miller et al., 1981).  Secretion of LH at this time resurges, due to 
the rise in GnRH secretion coupled with the development of steroidogenically competent 
follicles, which elevate peripheral estrogen concentrations (Sharp and Davis, 1993).  Mares at 
this time may exhibit long periods of erratic estrus, and their receptivity to a stallion can be 
ambiguous (Hines et al., 1991). 
Folliculogenesis and follicular waves 
 The primary functional unit of the ovary is the follicle.  The process of growth and 
differentiation of ovarian follicles is called folliculogenesis.  There are 3 phases to this process: 
selection, dominance, and then ovulation or atresia (Pierson, 1993).  Follicles have both 
endocrine and exocrine functions.  Both estrogens and protein hormones are produced and 
released by follicles, as well as expulsion of the oocyte at ovulation.  Control of ovarian activity 
is exerted through a myriad of processes: endocrine (systemic hormone release); paracrine (local 
intracellular diffusion); and autocrine (release of substances that bind to the cell’s own receptors) 
(Pierson, 1993). 
The mare, like other mammalian females, is born with a finite number of primordial 
follicles on her ovaries (Ginther, 1992).  A primordial follicle is a simple oocyte surrounded by 
one layer of cells.  Ginther (1992) classifies antral follicles into 3 categories based on size: small 
(2 to 10 mm), medium (11 to 24 mm), and large (≥ 25 mm).  During the preovulatory stage, the 
number of small follicles decreases; they subsequently increase during the postovulatory stage 
(Pierson, 1993).  There is a relatively constant number of medium follicles throughout the cycle, 
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and the number of large follicles is dependent upon follicular waves (Pierson, 1993), which will 
be explained further. 
A group of small follicles is constantly growing and regressing independent of 
reproductive status, providing a cohort from which large follicles are selected (Ginther, 1992).  
From here, pre-antral follicles develop.  This stage is marked by growth of the oocyte, formation 
of the zona pellucida, and division of granulosa cells into cuboidal epithelium (Pierson, 1993).   
Upon development of the antrum, which occurs around 300 µm in the mare, the follicle is said to 
be a tertiary follicle.  Further development will occur, including an increase in volume of the 
antrum and thickening of the follicular wall (Pierson, 1993). 
The vast majority, 99%, of follicles that develop to the antral stage are not destined for 
ovulation, but rather for atresia.  When a follicle goes atretic, it undergoes a gradual reduction in 
size and activity, eventually disappearing from the ovary.  The rest ovulate (Pierson, 1993). 
The gonadotropins are highly involved in regulation of follicular growth, despite the fact 
that they are not needed for development to the antral stage.  They are, however, necessary for 
continued growth.  In pre-antral follicles, LH and FSH receptors are acquired in the thecal and 
granulosa cell membranes, respectively (Pierson, 1993).  Under the influence of LH, the thecal 
cells produce androgens, which then pass through the basal lamina and are aromatized to 
estrogens by the granulosa cells under the control of FSH.  The rise in estrogen feeds back 
positively on LH secretion, which further increases estrogen production.  There is a 
corresponding increase in LH receptors.  This marked increase in estrogen production indicates 
the transition from the antral stage to the preovulatory stage.  The follicle will fail to reach the 
final stages of development without the capability to respond to the gonadotropins (Pierson, 
1993). 
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 Growth and selection of large follicles seems to occur in “waves” in mares, as in other 
species (Ginther, 1992; Pierson, 1993).  Follicular waves can be attributed to bimodal and 
unimodal FSH surges, according to Pierson (1993).  Ginther and Bergfelt (1993) also attribute 
follicular waves to increases in FSH concentrations.  When several follicles grow in synchrony 
(equal size and rate of growth), with eventual dissociation, this constitutes a major follicular 
wave (Ginther, 1992).  Dissociation, also known as divergence, is the selection of a dominant 
follicle for continued development.  Subordinate (smaller) follicles will begin to undergo atresia 
at this point (Ginther, 1992).  All mares will experience at least one follicular wave per cycle, 
with some having two.  When two waves occur, the first wave is the secondary wave, happening 
during late estrus to early diestrus.  Dominant follicles formed in this wave typically become 
static and regress; however, occasional diestrus ovulations do occur.  The primary wave is the 
second wave during mid-diestrus.  A dominant follicle from this wave will become the ovulatory 
follicle (Ginther, 1992). 
Ginther et al. (2001) explain that FSH concentrations decrease once a follicle reaches 
approximately 13 mm.  The follicles themselves cause this decrease.  Estradiol, free IGF-1, 
activin-A, and inhibin-A begin to increase differentially in the dominant follicle just before 
deviation.  Deviation occurs due to higher responsiveness by the dominant follicle to the 
gonadotropins.  Deviation is marked by the two largest follicles reaching an average size of 19.0 
to 22.5 mm.  Since FSH concentrations have already decreased, only the most developed 
follicles will continue to grow.  Continued production of estradiol and inhibin by the dominant 
follicle causes atresia of the subordinate follicles (Ginther, 1992; Pierson, 1993). 
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Ovulation and the luteal phase 
 Mares differ from females of other species in how they ovulate the dominant follicle.  
Rather than expelling the oocyte and follicular fluid from the exterior surface of the ovary, mares 
ovulate from an ovulation fossa (Ginther, 1992; Pierson, 1993).  Mares also have LH receptors in 
the granulosa cells of the dominant follicle, allowing for response to increasing LH 
concentrations during estrus (Ginther, 1992).  The LH peak does not occur in the mare until 
approximately 1 d post-ovulation, suggesting it is the rise in LH, rather than the peak as in other 
species, that causes ovulation in the mare (Pierson, 1993). 
Ovulation is the start of the luteal phase.  This phase of the cycle is dominated by 
progesterone secreted by the CL, which is fully formed by d 3 (Niswender and Nett, 1993).  
Luteinizing hormone is required by the CL in the mare for continued function.  Progesterone 
increases receptors for LH.  Around d 14, if the mare is not pregnant, the uterus will secrete 
prostaglandin-F2α, which lyses the CL and causes progesterone to drop, allowing the estrus cycle 
to begin again. 
Leptin 
Leptin is a 16-kDa protein hormone secreted primarily by white adipocytes.  It plays a 
role in multiple bodily processes including regulation of food intake, energy expenditure, and 
energy balance in rodents and humans (Houseknecht et al., 1998).  Many of leptin’s effects on 
food intake and energy regulation are thought to be controlled by neurotransmitters such as 
neuropeptide Y (NPY; Houseknecht et al., 1998).  Leptin has also been found to play a 
regulatory role in insulin secretion by β cells of the pancreas and insulin action and metabolism 
in adipocytes and skeletal muscle as well as regulation of nutritional effects on reproduction 
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(Houseknecht et al., 1998).  Its potential implications on the treatment of obesity could be quite 
profound. 
Leptin’s discovery process began in 1950 with the identification of a model for obesity, 
the ob/ob mouse (Ingalls et al., 1950).  These mice possessed a recessive mutation resulting in 
sterility in adult individuals and over 50% body fat.  Later, a similar mutation was identified in 
another strain of mice, and they were termed db/db mice (Hummel et al., 1966).  These animals 
were also obese, but were also hyperglycemic.  Subsequently, parabiosis studies (cross-
circulation) were conducted by Coleman (1973).  A pairing of ob/ob mice with db/db mice 
resulted in decreased food intake and weight loss in the ob/ob individuals and a sustained 
increase in food intake and weight in the db/db individuals.  Coleman concluded that the ob/ob 
mice were deficient in some factor regulated and produced by adipose tissue, but their brains 
could respond when exposed to it.  Conversely, the db/db mice produced the factor, but were 
immune to it.  Due to a lack of the necessary biotechnology available at the time, it would not be 
until much later that these hypotheses could be tested and verified. 
Twenty years later, the leptin gene was finally identified and cloned by Zhang et al. 
(1994).  The gene encoding the leptin receptor was cloned a year later (Tartaglia et al., 1995).  
Leptin has a helical structure that suggested its receptors would be similar to those of cytokines, 
which was confirmed when it was determined that the receptors were like those of class I 
cytokines (Tartaglia et al., 1995).  The signal transduction mechanism of leptin receptors in the 
hypothalamus is activated via the JAK-STAT pathway (Houseknecht et al., 1998).  It’s unclear at 
this point if any similarities in signaling exist beyond the JAK-STAT pathway (Houseknecht et 
al., 1998).  Leptin receptors are found throughout the body despite the fact that leptin is primarily 
produced and secreted by adipocytes (Kline et al., 1997); other tissues, including the placenta 
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(Hoggard et al., 1997), stomach (Bado et al., 1998), and muscle (Wang et al., 1998), produce 
much lesser amounts.  The long form of the receptor is almost solely located in the hypothalamus 
and absent in the peripheral bodily tissues (Mercer et al., 1996; Schwartz et al., 1996), while the 
short form is more diffusely expressed (Houseknecht et al., 1998).  It is possible that some of 
these short receptor forms are involved in transporting leptin through the bloodstream and across 
the blood-brain barrier (Devos et al., 1996). 
Research has shown that leptin serves not only as a signal of energy stores to the brain, 
but also as a signal of energy balance.  Leptin expression and secretion reflect body mass in both 
rodents and humans (Frederich et al., 1995a; Maffei et al., 1995; Considine et al., 1996) and are 
highly correlated with adipocyte size (Houseknecht et al., 1996a,b) when in a fed, zero energy 
balance state.  However, slight alterations to energy states cause drastic changes in correlation.  
Short spans of feed deprivation (12 to 48 h) result in rapid and severe decreases in leptin gene 
expression (Cusin et al., 1995; Frederich et al., 1995b; Trayhurn et al., 1995; Kolaczynski et al., 
1996a).  Even subtle changes have dramatic effects.  A mere 10% loss of body weight will cause 
serum leptin concentrations to fall 53% (Considine et al., 1996).  Likewise, a 10% weight gain 
causes a 300% increase (Kolaczynski et al., 1996b). 
Dramatic results have been observed in studies where leptin was administered to test 
subjects.  Decreases in feed intake (dependent upon dose), weight loss, loss of fat depots, and 
increases in energy metabolism have all been observed (Pelleymounter et al., 1995; Levin et al., 
1996).  It is remarkable that the weight losses following leptin treatment are sustained for several 
weeks following cessation of treatment (Chen et al., 1996; Azain et al., 1997).  This may mean 
that the loss comes not only from decreases in food intake, but also from an increased 
metabolism (Houseknecht et al., 1998). 
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Leptin has an inhibitory effect on NPY.  Apparently, this effect is manifested through an 
inhibition of synthesis of NPY in the hypothalamus (Houseknecht et al., 1998).  This 36-amino 
acid neuropeptide is a potent stimulator of food intake and an inhibitor of gonadotropin secretion 
(Houseknecht et al., 1998).  Neuropeptide Y increases in the hypothalamus and spinal fluid in 
cases of undernourishment (Houseknecht et al., 1998).  However, there is evidence that NPY is 
not the sole target of leptin.  Erickson et al. (1996b) produced ob/ob mice with no NPY (knock-
out mice) resulting in reduced phenotypic obesity, but body weight was not completely 
normalized.  Normal mice with knocked out NPY also had normal control of food intake and 
body weight with normal response to leptin (Erickson et al., 1996a). 
Multiple reports indicating that treatment with leptin led to a reduction in body weight led 
to speculation that leptin would be a “cure all” for obesity (Houseknecht et al., 1998).  However, 
subsequent research has led to the knowledge that leptin’s effects are much more complicated 
than just on weight loss.  In the realm of agriculture, obesity is not a primary concern for 
producers, but improving production efficiency is.  Optimization of reproductive performance 
through regulation of energy metabolism could be economically beneficial (Houseknecht et al., 
1998). 
Research has shown that leptin concentrations are affected by multiple factors, including 
species, age, gender, nutritional status, and season.  Leptin concentrations are strongly correlated 
to body condition in humans, ruminants, and horses (Prolo et al., 1998; Chilliard et al., 2000; 
Fitzgerald and McManus 2000; Gentry et al., 2002a,b).  Furthermore, Cartmill and associates 
(2003b) found that obese mares possess a permanent variation in leptin concentrations.  These 
findings indicate a possibility that a genetic determination exists for hyperleptinemia.  In horses, 
Cartmill (2004) determined that mares and geldings have higher leptin concentrations than 
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stallions, which could not be totally attributed to stallions just being leaner.  Conversely, Buff et 
al. (2002) found no differences between geldings and stallions in leptin concentrations.  In that 
study, body condition was examined and compared to leptin concentrations in general; however, 
specific averages were not given. 
Leptin is also influenced by age in horses.  Younger mares (< 5 years of age) are usually 
leaner with lower leptin concentrations than their older (> 10 years) counterparts (Fitzgerald and 
McManus, 2000; Buff et al., 2002).  As mentioned earlier, feed restriction affects circulating 
leptin concentrations.  Gentry et al. (2002a) found that long-term feed restriction resulted in both 
lower body condition scores and lower leptin concentrations.  In addition, throughout the 
duration of the study (September through January), leptin concentrations declined in all mares, 
regardless of body condition.  Likewise, a decrease in leptin concentrations was seen following 
short-term feed restriction in aged and young mares (McManus and Fitzgerald, 2000), with no 
corresponding change in body condition.  These results were in contrast to a previous study 
finding changes in leptin following a decrease in fat mass (Ahima et al., 1996). 
Initial evidence that leptin was related to reproductive function began in the mid-1990’s.  
Recall that ob/ob mice with greater than 50% body fat were sterile until cross-circulated with 
db/db mice and exposed to leptin.  The exposure to leptin restored normal reproductive function 
in these animals.  In addition, both males and females experienced a gain in gonadal weight, 
increased concentrations of circulating gonadotropins, and an increase in the number of ovarian 
follicles or sperm count (Barash et al., 1996; Chehab, 1997; Mounzih et al., 1997). 
Leptin not only restores fertility in deficient animals, but is also involved in the onset of 
puberty.  Leptin has been reported to be required for the normal onset of puberty (Chehab et al., 
1997).  Puberty was hastened in both well-fed and malnourished mice by treatment with leptin 
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(Ahima et al., 1996; Chehab et al., 1997).  In humans, there is a severe delay in menarche in 
individuals with severely low body condition and corresponding low leptin concentrations 
(Frisch et al., 1980).  Both boys and girls experience a rise in leptin concentrations around the 
time of onset of puberty, but only the females maintain this increase.  Males, on the other hand, 
experience a decline in leptin concentrations after the onset of puberty (Mantzoros et al., 1997; 
Cunningham et al., 1999). 
Leptin also varies with season.  In mares, leptin concentrations decrease drastically 
between fall and winter (Fitzgerald and McManus, 2000; Gentry et al., 2002a) and rise from July 
until September.  Likewise, in cattle, leptin increases from early winter through the summer 
solstice (Garcia et al., 2002).   
In a study previously mentioned, long-term feed restriction (5 months) led to lower 
plasma leptin concentrations as well as decreased body condition in mares (Gentry et al., 2002a).  
In that same study, mares with low body condition scores (3.0 to 3.5) underwent a longer winter 
anovulatory period, while all but one of their high body condition counterparts continued to 
cycle or have significant follicular activity throughout the winter.  The mares that became 
reproductively quiescent also had decreased leptin, IGF-1, and prolactin concentrations.  Also of 
note was that a dichotomy of leptin concentrations was observed (mares with <5 ng/mL vs. those 
7 to 20 ng/mL), even though body conditions were similar, indicating other factor(s) may be 
influencing leptin concentrations under conditions of high body condition (Gentry et al., 2002a).  
Later observations of the same mares up to 3 yr later showed sustained differences of circulating 
leptin concentrations (L. R. Gentry, unpublished), indicating that some innate factor, perhaps 
genetic, affected leptin concentrations. 
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Rationale for present research 
 Numerous reports have indicated a strong relationship between leptin and reproductive 
function.  Due to pressure on the equine industry to breed mares to foal as near to January 1 as 
possible, various methods have been and are being studied to facilitate this demand.  Leptin has 
long been suspected as a signal to the brain of reproductive status.  Additionally, Waller and co 
workers (2006) showed that no reproductive differences exist between hyperleptinemic vs. 
normal leptin mares of high body condition with respect to day of first ovulation after January 7 
or number of follicles.  These researchers also saw evidence that numerous mares on the project 
had luteal tissue prior to d 0, indicating ovarian activity during winter.  This, coupled with the 
fact that many high body condition, hyperleptinemic mares fail to enter an anovulatory state 
during winter (Gentry et al., 2002a), gave rise to the question as to whether or not treatment with 
leptin in mares with normal leptin concentrations would send a signal to the brain allowing the 
mare to return to normal cyclicity earlier in the year.  The experiment described herein was 
designed to determine if administration of exogenous recombinant equine leptin would induce 
early cyclicity in seasonally anovulatory mares.  Paralleling these observations, data were 
collected to determine any coincident metabolic effects that might be attributed to the leptin 
treatment.  
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MATERIALS AND METHODS 
Mares and Monitoring.  Beginning on December 22, 2005, 47 light horse mares were 
examined via transrectal ultrasonography (Aloka 550V with 5-MHz linear-array transducer; 
Aloka Science and Humanity, Wallingford, CT) to determine follicular activity.  Any mares with 
follicles >25 mm were eliminated from the pool of mares eligible for the project.  A blood 
sample was also collected via jugular venipuncture into 7 mL sodium heparin-coated tubes 
(Vacutainer, Becton and Dickinson, Franklin Lakes, NJ) from mares with no follicles <25 mm.  
Following the initial ultrasound exam and blood sample, a twice-weekly regimen of ultrasound 
and blood sampling was implemented. 
After 3 wk of sample collection, radioimmunoassay was performed on all blood samples 
to determine plasma progesterone concentrations using commercially available reagents 
(Diagnostic Laboratory Systems, Webster, TX).  A mare was classified as anovulatory if all 
blood samples were < 1 ng/mL.  Only mares with < 25 mm follicles that were also anovulatory 
were considered for the experiment. 
Twenty light horse mares were randomly selected from the pool of eligible horses.  On 
January 5, 2006, the horses were assessed for body condition score (Henneke et al., 1983).  Body 
condition scores ranged from 4.5 to 6.0, with an average of 5.4.  The horses were also weighed.  
Weights ranged from 339 kg to 516 kg, with an average of 462 kg.  Ages of the mares ranged 
from 6 to 17 yr, with an average of 11.8 yr.  The 20 horses were paired (matched) as closely as 
possible based on age, body condition score, and weight; one mare from each pair was then 
randomly assigned to one of two treatment groups: leptin-treated (n = 10) and controls (n = 10). 
Mares were maintained together on pasture (available native grasses) and were 
supplemented with good quality bermudagrass hay as needed throughout the duration of the 
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project.  Beginning on January 7 (d 0), leptin-treated mares received i.m. injections of 10 mg of 
recombinant equine leptin (provided by Dr. A. Gertler, Hebrew University of Jerusalem, 
Rehovot, Israel) in saline (1 mL); injections were repeated daily for 45 d.  Control mares 
received injections of 10 mg of inert protein (gelatin) in 1 mL saline daily for 45 d. 
Blood samples were collected every 3 d before treatment starting on d -2.  Mares were 
also examined via ultrasonography twice weekly to monitor ovarian activity.  When a mare was 
found with a follicle ≥ 25 mm, she was scanned daily until ovulation.  Blood samples were also 
collected daily once a follicle ≥ 25 mm was present until 5 d post-ovulation. 
Body weights were recorded for all mares on d -2, 16, 31, 47, 107 and 121 as a means of 
assessing the potential effect of leptin on weight loss.  On d 26 or 27, mares were confined to 
individual pens and hay consumption was recorded over a 24-h period to assess appetite.  On d 
35 or 39, a period of frequent blood sampling (every 30 min) was included to characterize 24-h 
hormonal patterns.  Blood samples were collected via indwelling jugular catheters and placed in 
12 x 75 mm borosilicate glass tubes containing 50 IU sodium heparin (Sigma Chemical Co., St. 
Louis, MO).  All blood samples were routinely centrifuged within 30 min of collection; plasma 
was harvested and stored at -20˚C. 
Sample Analyses.  Leptin was measured in daily plasma samples via radioimmunoassay 
previously validated for equine samples (Cartmill et al., 2003a).  Daily concentrations of 
triiodothyronine and thyroxine were evaluated using commercially available reagents (ICN 
Pharmaceuticals, Costa Mesa, CA; Kits 07-290102 and 07-292102, respectively).  Prolactin, 
growth hormone, and insulin concentrations were measured in both daily and frequently 
collected samples using radioimmunoassays previously validated for horse samples (Colborn et 
al., 1991; Thompson et al., 1992; Depew et al., 1994).  Intra- and interassay CV and assay 
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sensitivities were 6%, 4%, and 0.2 ng/mL for leptin; 5%, 8%, and 3.7 ng/dL for triiodothyronine; 
5%, 9%, and 1.2 µg/dL for thyroxine; 7%, 12%, and 0.2 ng/mL for prolactin; 8%, 11%, and 0.5 
ng/mL for GH; and 5%, 8%, and 0.5 mIU/L for insulin. 
After completion of the experiment, aberrations in the leptin assay consistent with 
antibody formation against the recombinant equine leptin were observed.  To test this possibility, 
4-µL samples of plasma from all mares from before treatment and then weekly after treatment 
were mixed with 200 µL (18 nCi) of I125-labeled human recombinant leptin (about 2 ng in 200 
µL phosphate buffered saline; Sigma).  After 24 h incubation at 4˚C, the equine gamma globulin 
fraction was precipitated with 100 µL of rabbit anti-equine-gamma-globulin serum.  The pellet 
was harvested by centrifugation (1,200 x g for 30 min), washed once with 1 mL of cold buffer, 
and then assessed for radioactivity in a solid scintillation counter. 
Statistical Analyses.  Data were analyzed by the Proc Mixed procedure of SAS (SAS 
Institute Inc., Cary, NC).  Data from both daily and frequent samples were analyzed for effects of 
treatment, time, and treatment by time interactions with repeated measures.  Single point 
variables were analyzed via one-way ANOVA.  For the period of frequent sampling (24-h 
window), the main effect of treatment and its interaction with time were analyzed using the Proc 
Mixed procedure of SAS.  When a significant F was detected (P < 0.05) the least significant 




On d 26 after the start of the project, one mare from the leptin-treated-group was 
euthanized as a result of a non-treatment related infection.  Due to the fact that she did not 
complete the treatment, her information is not included in any of the results, bringing the number 
of treated mares to 9. 
 Leptin-treated mares lost more weight (P < 0.0001) as a percentage of pretreatment body 
weight than did control mares during the first 31 d of the experiment (Figure 1).  However, there 
was no difference (P = 0.47) in hay consumed between groups under the conditions of the 24-h 
assessment period (Table 1).  Mean ages, body condition scores, and dates of first ovulation are 
presented in Table 2.  Ages and body condition scores were similar (P > 0.1) between groups.  
The day of first ovulation relative to the start of the project (January 7) for the leptin-treated 
mares did not differ (P = 0.167) from that control mares (Table 2).  Additionally, there were no 
differences (P > 0.1) in follicular activity (based on size of largest follicle) between groups 
during treatment (Figure 2). 
There was no effect (P > 0.1) of leptin treatment on daily prolactin concentrations (Figure 
3).  Daily treatment with leptin also did not affect (P > 0.1) daily triiodothyronine concentrations 
(Figure 4).  However, leptin-treated mares did have lower (P = 0.016) daily thyroxine 
concentrations than controls (Figure 5). 
There was no effect (P > 0.1) of leptin treatment on plasma concentrations of either 
growth hormone (Figure 6) or prolactin (Figure 7) during the 24-h blood-sampling period.  There 
was a tendency (P = 0.11) for leptin-treated mares to have lower insulin concentrations during 




































Figure 1.  Mean body weights collected on d –2, 16, 30, 46, 107, 121, expressed as a percent of 
pretreatment weight.  Leptin-treated mares lost more weight (P < 0.0001) during the first 30 days 













Table 1. Mean hay consumption, in kg and as a percent of body weight, consumed 
by leptin-treated and control mares 
 
 Treatment group  
Item Control a Leptin-treated b P-value 
Kg, hay 




1.16 1.05 0.47 
  aN = 10 




Table 2.  Mean age, body condition score (BCS), and day of first ovulation relative to the  
start of treatment (January 7).  Data are expressed as mean (range). 
 
 Treatment group  
Item Controla Leptin-treatedb P-value 
Age 11.3 (6 – 17) 12.4 (9 – 16) 0.39 
BCS 5.5 (4.5 – 6.0) 5.4 (4.5 – 6.0) 0.81 
Day of first 
ovulation 81.0 (30.0 – 103.0) 93.0 (72.0 – 106.0) 0.17 
  aN = 10 


















































Figure 2.  Mean size of largest follicle of leptin-treated versus control mares from day  
–2 relative to the start of scanning (January 5) through day 72 (March 19).  There was no 





















































Figure 3.  Mean plasma concentrations of prolactin for leptin-treated mares versus control mares 
from day –2 relative to the start of project (January 7) through day 57.  No effect (P > 0.1) of 
















































Figure 4.  Mean plasma concentrations of triiodothyronine (T3) in leptin-treated mares versus 
control mares from d –2 relative to the start of the project (January 7) through day 57.  No effect 



















































Figure 5.  Mean plasma concentrations of thyroxine for leptin-treated and control mares from 
day –2 relative to the start of the project (January 7) through day 57.  Leptin-treated mares had 














































Figure 6.  Mean plasma concentrations of growth hormone (GH) in leptin-treated mares versus 
control mares during a 24-h, frequent (every 30 min) blood-sampling window.  No effect of 






















































Figure 7.  Mean plasma concentrations of prolactin in leptin-treated mares versus control mares 
during a 24-h, frequent (every 30 min) blood-sampling window.  No effect of treatment was 

















































Figure 8.  Mean plasma concentrations of insulin in leptin-treated mares versus control mares 
during a 24-h, frequent (every 30 min) blood-sampling window.  There was a tendency (P = 
0.11) for leptin-treated mares to have lower insulin concentrations during the sampling window. 
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 Assessment of possible antibody formation against the injected recombinant equine leptin 
by means of radiolabeled leptin and immunoprecipitation of the horses' IgG fraction in a 4-µL 
plasma sampled revealed that leptin-treated mares had elevated (P < 0.001) antibody 
concentrations relative to control mares (Figure 9).  This elevation was rapid, occurring within 




















Figure 9.  Mean number of counts of radiolabeled human leptin immunoprecipitated from 4-µL 
samples of plasma from leptin-treated and control mares in the first 57 d of treatment.  There 
were more (P < 0.001) counts precipitated with the IgG fraction of the sample in leptin-treated 
mares than in control mares beginning on d 12. 




















 Immunoprecipitation of the gamma globulin fraction of selected plasma samples from all 
mares, after incubation with radioiodinated leptin, revealed that leptin-treated mares had 
produced significant antibodies to the injected recombinant equine leptin by d 16 of the 
experiment.  This possibility was first raised by perturbations in the leptin radioimmunoassays 
performed at the end of the experiment.  That is, assay tubes with samples from treated mares 
around d 10 to 19 had much more radioactivity in them after the final centrifugation step than 
was in the buffer control (zero standard) tubes.  These latter tubes theoretically should contain 
the highest amount of labeled, precipitated leptin, bound by the primary antibody of the assay.  
The higher counts indicated that some other factor was causing precipitation of the labeled 
hormone.  Given that the initial humoral immune response to a foreign protein involves mainly 
IgM antibodies (Guyton and Hall, 2000), which have 10 binding sites and a MW approximately 
5 times that of IgG, it is likely that the high counts in the assay were due to IgM forming immune 
complexes with the labeled hormone.  These complexes, just like the primary-secondary 
antibody complexes normally formed in the assay, would precipitate due to their large size, and 
would carry with them the labeled leptin.  As the immune response to the injected equine leptin 
proceeded, IgM antibodies would diminish and IgG antibodies would become predominant in the 
plasma samples (Guyton and Hall, 2000).  These antibodies do not typically precipitate in the 
presence of antigen such as leptin, thus their effect on the leptin radioimmunoassay would be 
quite different.  Rather than observing higher than expected counts, the anti-leptin IgG in the 
samples would compete with the primary antibody in the assay, tying up large amounts of the 
labeled hormone that would normally bind to the primary antibody.  Given that the second 
antibody only precipitates the primary (rabbit) antibody, the amount of labeled leptin precipitated 
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would be much less than normal, which is interpreted in the assay calculation as very high leptin 
concentration in the sample.  This is exactly what was observed in the leptin assays on samples 
from treated mares:  an initial odd "extra counts" period in samples from around d 10 to 19, 
followed by a decrease to somewhat normal, and then a rapid skyrocketing of calculated leptin 
levels to values well beyond the expected physiologic range, even for injected mares.  The 
timing of this apparent immunological response to the injected recombinant equine leptin would 
indicate that the protein was immediately detected as "foreign" from d 1.   
 This immunological response to injected recombinant leptin is similar to that described 
by Thompson et al. (1997) for recombinant porcine prolactin.  In that experiment, mares treated 
with prolactin during the seasonal anovulatory period immediately began to shed their winter 
hair coat, and most ovulated within a few weeks.  However, the hair shedding slowed by 5 wk of 
treatment and totally ceased by 7 wk; thereafter, the mares did not lose any more hair even 
through May (control mares shed around April 1 and were complete by mid-April).  Post-
experimental testing showed that the prolactin-treated mares had developed antibodies against 
the recombinant protein, even though the homology with the known equine protein was greater 
than 93% (Thompson et al., 1997).  Thus, the question in the present experiment, just like in that 
of Thompson et al. (1997), is when the treated mares should be considered "leptin-treated" as 
opposed to when they might be considered "neutralized" due to the presence of antibodies 
against the injected leptin.  The presence of antibodies does not necessarily mean neutralization 
of the biological activity of the injected leptin; however, it is a likely result.  Based on the 
immunoprecipitation data, the time of transition from treated to start of neutralization was around 
d 16, thus discussion of the results will reflect this limitation in the experiment.   
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 The increased weight loss observed in the leptin-treated mares was consistent with 
previous research in other species indicating that treatment with leptin causes weight loss, loss of 
fat, and increases in energy metabolism (Pellymounter et al., 1995; Levin et al., 1996).  
Moreover, the weight loss was apparent by the first assessment on d 16, about the time when 
antibodies to leptin were beginning to rise in these mares.  The leptin-treated mares continued to 
lose weight, however so did the control mares, thus the drop from d 16 to 31 could reflect only 
the environmental conditions of the time.  Previous research in other species has shown that 
exogenous leptin decreases food intake (Pellymounter et al., 1995; Levin et al., 1996).  The fact 
that there was no difference between groups when intake was assessed on d 26 and 27 could be 
due to a lack of effect of leptin on intake, or more likely, the fact that neutralization of the 
injected leptin had masked any possible effects.  Although leptin treatment reduces food intake 
in smaller species, it also increases metabolic rate (Houseknecht et al., 1998), which contributes 
to weight loss as well. 
 Previous research has indicated that many mares with high body condition score and high 
leptin concentrations fail to enter an anovulatory state, continuing to display estrous cycles or 
having significant follicular activity during the winter (Gentry et al., 2002a); therefore the 
absence of differences in reproductive characteristics observed between treatment groups was in 
contradiction to previous studies.  Date of first ovulation did not differ between groups, nor were 
there any differences in the size of the largest follicles at any point during the project.  The mean 
dates of ovulation were d 81 (March 29) and d 93 (April 10) for controls and leptin-treated 
mares, respectively, meaning that all of the mares ovulated close to what is considered to the be 
predicted date of early April (Henneke et al., 1983; Sharp and Davis, 1993).  The mares on this 
project were not of high body condition, so the lack of a difference could be attributed to their 
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lower body condition.  Additionally, research has shown that even slight reductions in weight 
dramatically affect leptin concentrations.  A loss of only 10% of body weight will cause serum 
leptin concentrations to fall by 53% (Considine et al., 1996).  Leptin-treated mares lost an 
average of 6.3% of their pretreatment body weight. 
Leptin has a stimulatory effect on prolactin in other species (Yu et al., 1997; Macajova et 
al., 2004).  Kelley et al. (2006) showed that prolactin is a key component in the early onset of 
cyclicity in mares.  In the present experiment, there was no difference in prolactin in either 
frequent or daily blood samples, nor was there any elevation of prolactin to levels consistent with 
those seen in previous work where there was an early onset of cyclicity (Kelley et al., 2006). 
Previous results have indicated that hyperleptinemic horses have higher concentrations of 
triiodothyronine than normal horses, but similar concentrations of thyroxine (Cartmill et al., 
2003a).  Triiodothyronine is the more biologically active of the thyroid hormones, however 
thyroxine is thought to exert negative feedback on the hypothalamus (Hadley, 2000).  Higher 
levels of thyroid hormones are associated with weight loss. We would expect to see higher levels 
of both thyroid hormones in treated horses due to the weight loss, but this was not the case as 
there was no effect of treatment on triiodothyronine, and thyroxine was lower in treated animals. 
Growth hormone is secreted in a pulsatile fashion; therefore it was analyzed over the 24-h 
blood-sampling window.  In previous studies, high leptin horses have exhibited lower circulating 
growth hormone (Gentry et al., 2002b; Cartmill et al., 2003a).  Our findings were in contrast to 
these previous finding, which may be due to a lack of effect on growth hormone secretion or may 
be attributable to antibody formation against the recombinant leptin. 
Leptin is known to directly inhibit β-cell secretion of insulin via alteration of ion channel 
function (Houseknecht et al., 1998).  The tendency for a reduction in insulin concentrations in 
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the 24-h blood sampling window in leptin-treated mares would be consistent with this model.  
Horses of high body condition score with hyperleptinemia also have relatively high circulating 
insulin concentrations (mares; Gentry et al., 2002b; Waller, 2005; mares and geldings; Cartmill 
et al., 2003a).  However, Cartmill et al. (2003a) showed that the cause-and-effect is likely the 
reverse; that is, infusion of insulin with a maintenance of normal glucose levels stimulated leptin 
secretion 8 h later, identical to what is seen normally after horses are fed a grain meal. 
In conclusion, treatment of seasonally anovulatory mares of average body condition with 
recombinant equine leptin reduced body weight and thyroxine concentrations, and tended to 
reduce insulin concentrations, relative to control mares.  The formation of circulating antibodies 
to the injected leptin within approximately 16 d complicates the interpretation of the results, 
because it is not known for sure whether the antibodies did in fact neutralize the biological 
activity of the injected leptin.  Thus, the lack of effect of treatment on prolactin, growth 
hormone, triiodothyronine, feed intake, ovarian activity, and day of first ovulation may be due to 
a true lack of effect of leptin, or may be due to antibody formation.  The reduction in body 
weight was an expected result, based on reports in other species, and confirms an initial positive 
biological response to the injected leptin.  The alterations in thyroxine, and perhaps insulin, may 
indicate that there was still a biological response through d 35 to 39. 
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SUMMARY AND CONCLUSIONS 
 In this experiment, no significant reproductive differences were found as a result of 
treatment with recombinant equine leptin.  This could be a result of the formation of antibodies, 
although their ability to neutralize the injected leptin was not determined.  Prior to antibody 
formation, leptin-treated mares lacked any advantage of significant follicular activity based on 
size of largest follicle.  However, the biological activity of the injected leptin was confirmed by 
the expected effects body weight in the first 16 d of treatment.  Control mares also lost weight 
after d 16, likely due to the winter conditions under which the project was conducted, but not as 
much as their leptin-treated counterparts.  It is reasonable to assume that previous results 
indicating continued cyclicity and ovarian activity through the traditional anovulatory season 
observed by Gentry and coworkers (2002a) were perhaps attributable more to the high body 
condition of the mares as opposed to their leptin status.  However, it is still possible that leptin 
plays a role, as we were not successful in inducing such an extreme difference.  With an altered 
recombinant equine leptin, the project could be attempted again with very different results if no 
antibody formation occurs.  It was also interesting that all mares ovulated within the normal, 
expected time period (April 1; Ginther, 1992), despite their lower body condition. 
 From a metabolic standpoint, effects on thyroxine and insulin secretion were in 
contradiction to results seen in hyperleptinemic, high body condition horses (Gentry et al., 
2002a; Cartmill et al., 2003a), but were consistent with the role of leptin in smaller species.
 In conclusion, treatment with recombinant equine leptin did not induce early onset of 
cyclicity and ovarian activity in winter, perhaps due to antibody formation against the injected 
leptin.  However, multiple metabolic effects were observed, including significant weight loss and 
altered thyroxine and insulin secretion. 
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